Roche Gets PR Help For Tamiflu
Share this
"Fleishman-Hillard is counseling Roche, which now says it is doing everything possible to meet the demand for Tamiflu, according to Michael Rinaldo, head of F-H's health group in New York," O'Dwyer's PR Daily reports. "Roche says it is 'doing everything possible' to meet demand for flu drug." The company's reputation took a hit last month when it appeared to be "more eager to protect its 'monopoly' on its Tamiflu - the vaccine most effective in fighting bird flu - than preventing a worldwide avian flu pandemic," O'Dwyer's writes.
Main Source:
O'Dwyer's PR Daily (sub req'd), November 8, 2005 - 1881 reads
- Printer-friendly version
- Add new comment
- permalink
Comments
the flu
So, from the point of view of PR Watch, what's the scoop on and behind the scenes of the flu pandemic?